AACR Annual Meeting 2023: Opening Ceremony Heralds Extraordinary Science
As 21,000 cancer researchers, clinicians, policymakers, and patient advocates thronged the Orange County Convention Center, Margaret Foti, PhD, MD...
AACR In the News
The American Association for Cancer Research (AACR) has appeared in numerous publications lately, showcasing the breadth of our mission...
FDA-AACR Workshop Examines the Practice and Promise of Real-world Evidence in Oncology
Building on advances in technology and analytical tools, real-world data (RWD) sources have attracted increasing interest as means to...
AACR Blog Turns 3: Check Out Our Top 10 Posts
Three years ago, the American Association for Cancer Research (AACR) launched this blog with a welcome post from Chief...
Molecular Targets 2021: The Latest Efforts to Overcome Resistance to KRAS Inhibitors
Once considered undruggable, mutant KRAS has emerged in recent years as a viable target for anticancer therapeutics. As a...
In the News: AACR President Nancy E. Davidson, MD, on Capturing the Moonshot’s Momentum
AACR President Nancy E. Davidson, MD, discusses her goals for her Presidential year at the AACR in an editorial...
Seeking Clues to Early-onset Colorectal Cancer
The 2020 death of actor Chadwick Boseman shocked the public, sparking grief in those who revered his portrayal of...
Editors’ Picks: November Highlights from the AACR Journals
With Thanksgiving behind us here in the United States, the holiday season is in full swing. So, grab some...
Experts Forecast Cancer Research and Treatment Advances in 2016
We asked experts in cancer precision medicine, immunotherapy, and prevention what breakthroughs we might expect to see in 2016...
Is Comprehensive Genomic Profiling Ready for Prime Time?
Next-generation genome analysis technologies allow for the sequencing of multiple genes at once to characterize the mutational profile of...
A Discussion with Cancer Discovery’s Editors-in-Chief
This year marks the 10th anniversary of Cancer Discovery, a journal of the AACR. To celebrate the anniversary, Cancer Discovery published a special anniversary issue, featured spotlights on groundbreaking articles on its website, and held the Cancer Discovery ...
Experts Forecast Cancer Research and Treatment Advances in 2019
In 2018, we witnessed significant momentum in several hot areas of cancer research, including immunotherapy and precision medicine. Researchers...
Can Big Data Launch Cancer Research?
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today In his 2016 State of the Union address, President...
2019 in Review: Progress Across Many Areas of Cancer Research
In 2019, research continued to drive progress across the spectrum of cancer care in the form of new and...
Eye on AI: Applying Artificial Intelligence to Drive Cancer Research, Part 1
Researchers highlighted AI's potential to enhance cancer research, including to discover cancer drivers and new therapeutic opportunities.
AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Keynotes Highlight Basic and Clinical Research
Cancers are driven by unique genetic alterations, so what if we targeted these alterations to treat the cancer? It seems...
AACR Annual Meeting 2019: Patients as Partners in the Research Process
In the past couple of decades, progress against cancer has created a new generation of survivors. Today, more than...
AACR Announces Call for Abstracts for AACR Annual Meeting 2022
The American Association for Cancer Research (AACR) is pleased to announce the Call for Abstracts for the AACR Annual...
Annual Meeting 2022: Opening Plenary Showcases Cutting-edge Scientific Program
Progress against cancer has been fueled not by a single discipline or a sole blockbuster discovery, but by incremental...
Daily Takeaways From the AACR Annual Meeting 2025: Saturday, April 26
The second day of the AACR Annual Meeting 2025 included a 5K run/walk, the conclusion of the Educational Program,...
AACR Virtual Annual Meeting I: A User’s Guide
As the COVID-19 pandemic swept the globe this spring, the American Association for Cancer Research (AACR) launched a major...
Record Year for AACR Annual Meeting 2024: Summary of Cutting-Edge Science and More!
A recap of the plenary sessions, cutting-edge science, clinical trials, and more covered by the AACR blog.
Vemurafenib Becomes First FDA-approved Treatment for a Rare Type of Blood Cancer
Recently, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic vemurafenib (Zelboraf) for treating certain adults...
10 Most Popular Cancer Research Catalyst Blog Posts of 2015
It’s that time of year when we reflect on the progress we made over the past 12 months –...
AACR Report Shines Light on Cancer Health Disparities
At the age of 40, Marlena Murphy was diagnosed with triple-negative breast cancer, an aggressive subtype that occurs twice...
Empowering Scholars Worldwide: Celebrating the First Anniversary of the Global Scholar Alumni Committee
The Global Scholar Alumni Committee reflects on their progress after the first year in helping the careers of young...
Cancer Disparities: The Gaps and Encouraging Progress
Insights from the AACR Cancer Disparities Progress Report 2024.
AACR Virtual Annual Meeting I: The Opening Session
In an extraordinary turn of events, the American Association for Cancer Research (AACR) Annual Meeting 2020 kicked off Monday...
The Fuzzy Factor: Striving to Protect Patient Privacy in Big Data Sets
A major objective of former Vice President Joe Biden’s National Cancer Moonshot Initiative is breaking down silos and sharing...
Risky Business: Breast Cancer Risk Factors and What We Know About Them
A look at recent research on determining breast cancer risk, the impact of lifestyle changes on cancer risk, and...